Synairgen plc (SYGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 9, 2026
Synairgen Market Cap
Synairgen has a market cap or net worth of $110.27 thousand as of October 20, 2026. It is the 51,135th most valuable company in the world and the 7,256th biggest in the United States. Its market cap has decreased by 99.72% in one year.
Market Cap
110.27K
Enterprise Value
-5.59M
Revenue
n/a
Global Rank
Country Rank
#7,256 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since July 20, 2020, Synairgen's market cap has decreased from 375.08M to 110.27K, a decrease of -99.97%. That is a compound annual growth rate of -76.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 110.27K | 9,896.92% |
| Dec 30, 2025 | 1.10K | -99.98% |
| Dec 31, 2024 | 5.78M | -42.64% |
| Dec 29, 2023 | 10.07M | -59.68% |
| Dec 30, 2022 | 24.97M | -95.55% |
| Dec 31, 2021 | 560.74M | 40.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regen BioPharma | 251.29K |
| Ampio Pharmaceuticals | 207.88K |
| Endonovo Therapeutics | 180.76K |
| Sigyn Therapeutics | 159.54K |
| Ocean Biomedical | 116.18K |
| Immunotech Laboratories | 114.99K |
| Innovation Pharmaceuticals | 105.75K |
| ProtoKinetix | 82.33K |